Related Experiment Video
Updated: Jul 3, 2026
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity
1National Centre for Multiple Sclerosis, B 1820 Melsbroek, Belgium. r.gonsette@skynet.be
Abstract:
In multiple sclerosis (MS) disability results from neuronal and axonal loss, the hallmark of neurodegenerative diseases (ND). Neurodegeneration is initiated by microglia activation and mediated by oxidative stress and excitotoxicity. The same sequence of events has been consistently observed in MS. However, microglia activation correlates with a marked cell infiltration in MS but not in ND. In both pathological states, peroxynitrite is the common initiating factor of oxidative stress and excitotoxicity and is thus a potential interesting therapeutic target. Oxidative stress leads to multiple lipid and protein damages via peroxidation and nitration processes. The pathomechanisms of excitotoxicity are complex involving glutamate overload, ionic channel dysfunction, calcium overload, mitochondriopathy, proteolytic enzyme production and activation of apoptotic pathways. The inflammatory component in MS is important for the design of therapeutic strategies. Inflammation not only causes axonal and neuronal loss but it also initiates the degenerative cascade in the early stage of MS. Potent anti-inflammatory agents are now available and it is not unreasonable to think that an early blockade of inflammatory processes might also block associated degenerative mechanisms and delay disability progression. The development of neuroprotective drugs is more problematic. Indeed, given the multiple and parallel mechanisms involved in neurodegeneration, modulation of a single specific pathway will likely yield a partial benefit if any.
Insights
Multiple sclerosis (MS) involves neurodegeneration driven by microglia activation, oxidative stress, and excitotoxicity. Early anti-inflammatory treatment may slow MS disability progression by blocking these degenerative processes.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) disability stems from neuronal and axonal loss, characteristic of neurodegenerative diseases (ND).
- Neurodegeneration in MS and ND shares common pathways including microglia activation, oxidative stress, and excitotoxicity, with peroxynitrite as a key initiator.
- MS pathology is distinguished by significant cell infiltration alongside microglia activation, unlike typical ND.
Purpose of the Study:
- To elucidate the shared and distinct pathomechanisms in multiple sclerosis (MS) and neurodegenerative diseases (ND).
- To identify peroxynitrite as a common therapeutic target in MS and ND.
- To explore the potential of early anti-inflammatory strategies in mitigating MS-related neurodegeneration and disability.
Main Methods:
- Comparative analysis of pathological mechanisms in MS and ND.
- Identification of key molecular mediators like peroxynitrite.
- Review of existing therapeutic strategies for inflammation and neuroprotection.
Main Results:
- Peroxynitrite is identified as a common initiating factor for oxidative stress and excitotoxicity in both MS and ND.
- Oxidative stress causes lipid and protein damage through peroxidation and nitration.
- Excitotoxicity involves complex mechanisms including glutamate excitotoxicity, ionic channel dysfunction, and apoptotic pathways.
Conclusions:
- Early blockade of inflammatory processes in MS may delay disability progression by inhibiting associated degenerative mechanisms.
- Targeting peroxynitrite offers a potential therapeutic avenue for both MS and ND.
- Developing effective neuroprotective drugs for MS is challenging due to the multifactorial nature of neurodegeneration.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
01:24Parkinson Disease ll: Pathophysiology
01:23Alzheimer Disease ll: Pathophysiology
01:25Secondary Spinal Cord Injury llI: Pathophysiology
01:15Parkinson's Disease: Overview
01:29Excitatory and Inhibitory Effects of Neurotransmitters